Compare SGHT & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | ASYS |
|---|---|---|
| Founded | 2011 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.6M | 263.7M |
| IPO Year | 2021 | 2006 |
| Metric | SGHT | ASYS |
|---|---|---|
| Price | $8.16 | $14.91 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.08 | N/A |
| AVG Volume (30 Days) | 206.2K | ★ 418.8K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $77,363,000.00 | ★ $79,364,000.00 |
| Revenue This Year | $11.67 | $2.82 |
| Revenue Next Year | $10.39 | $18.75 |
| P/E Ratio | ★ N/A | $80.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.19 | $6.75 |
| 52 Week High | $9.24 | $25.71 |
| Indicator | SGHT | ASYS |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 49.04 |
| Support Level | $8.00 | $13.62 |
| Resistance Level | $8.80 | $17.57 |
| Average True Range (ATR) | 0.35 | 0.66 |
| MACD | -0.15 | 0.15 |
| Stochastic Oscillator | 29.36 | 67.08 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.